Justifications for discrepancy in dissolution vs. BE study [Dissolution / BCS / IVIVC]

posted by gtomer – Israel, 2014-04-09 16:40 (4110 d 13:02 ago) – Posting: # 12799
Views: 6,176

Hi All,

Would value your opinion:

The bioequivalence guide (CPMP/EWP/QWP/1401 Rev 1) requests to perform a dissolution profile comparison at 3 pHs between the test and reference products used in the BE study.
It gives superiority to the BE study results, should the dissolution profiles will not be similar, "However, possible reasons for the discrepancy should be addressed and justified.".

Does anyone know of any investigatory methods or justifications found for such discrepancy, i.e. where reference vs. test found similar in BE study but F2>50 in dissolution?

Many thanks.

Complete thread:

UA Flag
Activity
 Admin contact
23,430 posts in 4,931 threads, 1,675 registered users;
86 visitors (0 registered, 86 guests [including 20 identified bots]).
Forum time: 05:42 CEST (Europe/Vienna)

It has yet to be proven
that intelligence has any survival value.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5